We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Bring photo ID to vote Check what photo ID you'll need to vote in person in the General Election on 4 July.
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
Batches of some products made by Legency Remedies Pvt Ltd have been found to contain a bacteria called Ralstonia pickettii (R. pickettii). All potentially affected batches are being recalled following an MHRA investigation.
Fresenius Kabi Limited have informed the MHRA of a packaging error with specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex and Freeflex PLUS.
The government has funded 350 additional medical school places in England for the academic year 2025 to 2026 in latest step to deliver NHS Long Term Workforce Plan.
New rules meaning over 180,000 Universal Credit claimants will have to look for more work have come into force today (Monday 13 May), as the Government helps people progress in work and off welfare.
Prime Minister Rishi Sunak makes a speech on defence.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
The Foreign Secretary will attend a meeting of the Alliance’s foreign ministers in Brussels and underline the need to sustain support for Ukraine.
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Sun Pharma UK Ltd has informed the MHRA of a labelling issue with one batch of Gemcitabine 2000mg/200ml infusion.
medac GmbH (t/a medac Pharma LLP) is recalling further batches due to particles detected during long-term stability tests.
Information for healthcare professionals and the public about the adapted Spikevax XBB.1.5 vaccine
The rules for manufacturing mercury added products in Great Britain, as well as importing and exporting them between Great Britain and non-EU countries.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Publication of the Secretary of State’s decisions following the Trade Remedies Authority’s extension review.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).